<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2013-12-03 09:39:23Cell therapy Adult stem cell Angiogenesis Mesenchymal stem cell Hematopoietic stem cell transplantation Pluristem Therapeutics Hematopoietic stem cell Placenta cord banking Biology Stem cells Cell biology |
| Pluristem Issues Letter to Shareholders HAIFA, Israel, February 07, Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, today reported financial resuDocID: 1uCYz - View Document |
| Ellenoff Grossman & Schole LLP 2015 Representative Registered Direct Transactions Areas of Practice Include: Pluristem TherapeuticsDocID: 1pWA5 - View Document |
| ISRAEL Small Country BIG IDEAS The disabled may walk again M ore than 2 million Americans may be able to walk again despite their lower limb disabilitiesDocID: 1puwc - View Document |
| Pluristem - PR - Effectiveness of PLX Cells (B1964939).DOCXDocID: 1p3Oj - View Document |
| PDF DocumentDocID: mC0V - View Document |